Ghofrani HA - Search Results

1

[Therapy of pulmonary arterial hypertension].

Voswinckel R, Reichenberger F, Gall H, Seeger W, Grimminger F, Ghofrani HA. Voswinckel R, et al. Among authors: ghofrani ha. Internist (Berl). 2009 Sep;50(9):1101-2, 1104-9. doi: 10.1007/s00108-009-2336-8. Internist (Berl). 2009. PMID: 19690823 Review. German.

2

Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo- and exotoxin.

Walmrath D, Ghofrani HA, Rosseau S, Schütte H, Cramer A, Kaddus W, Grimminger F, Bhakdi S, Seeger W. Walmrath D, et al. Among authors: ghofrani ha. J Exp Med. 1994 Oct 1;180(4):1437-43. doi: 10.1084/jem.180.4.1437. J Exp Med. 1994. PMID: 7931076 Free PMC article.

3

Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis.

Walmrath D, Günther A, Ghofrani HA, Schermuly R, Schneider T, Grimminger F, Seeger W. Walmrath D, et al. Among authors: ghofrani ha. Am J Respir Crit Care Med. 1996 Jul;154(1):57-62. doi: 10.1164/ajrccm.154.1.8680699. Am J Respir Crit Care Med. 1996. PMID: 8680699

4

Synergism of alveolar endotoxin "priming" and intravascular exotoxin challenge in lung injury.

Walmrath D, Ghofrani HA, Grimminger F, Seeger W. Walmrath D, et al. Among authors: ghofrani ha. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):460-8. doi: 10.1164/ajrccm.154.2.8756823. Am J Respir Crit Care Med. 1996. PMID: 8756823

5

Compartmentalized lung cytokine release in response to intravascular and alveolar endotoxin challenge.

Ghofrani HA, Rosseau S, Walmrath D, Kaddus W, Kramer A, Grimminger F, Lohmeyer J, Seeger W. Ghofrani HA, et al. Am J Physiol. 1996 Jan;270(1 Pt 1):L62-8. doi: 10.1152/ajplung.1996.270.1.L62. Am J Physiol. 1996. PMID: 8772528

6

Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs.

Ermert L, Ermert M, Goppelt-Struebe M, Walmrath D, Grimminger F, Steudel W, Ghofrani HA, Homberger C, Duncker H, Seeger W. Ermert L, et al. Among authors: ghofrani ha. Am J Respir Cell Mol Biol. 1998 Apr;18(4):479-88. doi: 10.1165/ajrcmb.18.4.2939. Am J Respir Cell Mol Biol. 1998. PMID: 9533935

7

[Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension].

Olschewski H, Walmrath D, Schermuly R, Ghofrani HA, Grimminger F, Seeger W. Olschewski H, et al. Among authors: ghofrani ha. Pneumologie. 1998 Jan;52(1):3-7. Pneumologie. 1998. PMID: 9540363 German. No abstract available.

8

Recovery from circulatory shock in severe primary pulmonary hypertension (PPH) with aerosolization of iloprost.

Olschewski H, Ghofrani HA, Walmrath D, Temmesfeld-Wollbrück B, Grimminger F, Seeger W. Olschewski H, et al. Among authors: ghofrani ha. Intensive Care Med. 1998 Jun;24(6):631-4. doi: 10.1007/s001340050628. Intensive Care Med. 1998. PMID: 9681789

9

Evidence for a role of protein kinase C in hypoxic pulmonary vasoconstriction.

Weissmann N, Voswinckel R, Hardebusch T, Rosseau S, Ghofrani HA, Schermuly R, Seeger W, Grimminger F. Weissmann N, et al. Among authors: ghofrani ha. Am J Physiol. 1999 Jan;276(1):L90-5. doi: 10.1152/ajplung.1999.276.1.L90. Am J Physiol. 1999. PMID: 9887060

10

Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.

Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbruck B, Grimminger F, Seeger W. Olschewski H, et al. Among authors: ghofrani ha. Am J Respir Crit Care Med. 1999 Aug;160(2):600-7. doi: 10.1164/ajrccm.160.2.9810008. Am J Respir Crit Care Med. 1999. PMID: 10430735 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

555 results

Search Page

Filters